- Home
- BMEA vs EUDA Comparison
BMEA vs EUDA Comparison
Compare BMEA & EUDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMEA
- EUDA
- Stock Information
- Founded
- BMEA 2017
- EUDA 2021
- Country
- BMEA United States
- EUDA Singapore
- Employees
- BMEA N/A
- EUDA N/A
- Industry
- BMEA Biotechnology: Pharmaceutical Preparations
- EUDA Blank Checks
- Sector
- BMEA Health Care
- EUDA Finance
- Exchange
- BMEA Nasdaq
- EUDA Nasdaq
- Market Cap
- BMEA 125.4M
- EUDA 139.3M
- IPO Year
- BMEA 2021
- EUDA N/A
- Fundamental
- Price
- BMEA $2.00
- EUDA $3.65
- Analyst Decision
- BMEA Buy
- EUDA
- Analyst Count
- BMEA 13
- EUDA 0
- Target Price
- BMEA $27.92
- EUDA N/A
- AVG Volume (30 Days)
- BMEA 636.9K
- EUDA 100.2K
- Earning Date
- BMEA 05-01-2025
- EUDA 01-01-0001
- Dividend Yield
- BMEA N/A
- EUDA N/A
- EPS Growth
- BMEA N/A
- EUDA N/A
- EPS
- BMEA N/A
- EUDA N/A
- Revenue
- BMEA N/A
- EUDA $3,811,496.00
- Revenue This Year
- BMEA $191.34
- EUDA $66.63
- Revenue Next Year
- BMEA N/A
- EUDA $119.95
- P/E Ratio
- BMEA N/A
- EUDA N/A
- Revenue Growth
- BMEA N/A
- EUDA N/A
- 52 Week Low
- BMEA $1.94
- EUDA $1.64
- 52 Week High
- BMEA $14.43
- EUDA $6.30
- Technical
- Relative Strength Index (RSI)
- BMEA 28.47
- EUDA 42.35
- Support Level
- BMEA $2.27
- EUDA $3.59
- Resistance Level
- BMEA $3.08
- EUDA $4.04
- Average True Range (ATR)
- BMEA 0.23
- EUDA 0.22
- MACD
- BMEA 0.00
- EUDA -0.02
- Stochastic Oscillator
- BMEA 2.95
- EUDA 9.38
About BMEA Biomea Fusion Inc.
Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.
About EUDA EUDA Health Holdings Limited
EUDA Health Holdings Ltd is a Singapore-based health technology company that operates a first-of-its-kind Southeast Asian digital healthcare ecosystem aimed at making healthcare affordable and accessible, The company's proprietary unified AI platform quickly assesses a patient's medical history, triages a condition, digitally connects patients with clinicians, and predicts optimal treatment outcomes. The company caters to all stages of care, including wellness and prevention, urgent care and emergencies, pre-existing conditions, and aftercare services. The company operates in two segments namely Medical services and property management services, out of which the company derives its maximum revenue from Medical services.